Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.

Kilburn JM, Lester SC, Lucas JT Jr, Soike MH, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ.

J Thorac Oncol. 2014 Apr;9(4):572-6. doi: 10.1097/JTO.0000000000000086.

PMID:
24736084
[PubMed - in process]
2.

Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone.

Lewis JA, Petty WJ, Harmon M, Peacock JE, Valente K, Owen J, Pirmohamed M, Lesser GJ.

J Oncol Pharm Pract. 2014 Feb 27. [Epub ahead of print]

PMID:
24576944
[PubMed - as supplied by publisher]
3.

Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment.

Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJ.

Radiother Oncol. 2014 Mar;110(3):505-10. doi: 10.1016/j.radonc.2013.11.017. Epub 2014 Jan 17.

PMID:
24444530
[PubMed - in process]
4.

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer.

Petty WJ, Laudadio J, Brautnick L, Lovato J, Dotson T, Streer NP, Weaver KE, Miller AA.

Int J Oncol. 2013 Dec;43(6):2057-63. doi: 10.3892/ijo.2013.2122. Epub 2013 Oct 3.

PMID:
24100924
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery.

Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD.

Neurosurgery. 2013 Oct;73(4):641-7; discussion 647. doi: 10.1227/NEU.0000000000000072.

PMID:
23842552
[PubMed - indexed for MEDLINE]
6.

Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial.

Socinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DE.

J Clin Oncol. 2012 Nov 10;30(32):3953-9. doi: 10.1200/JCO.2012.41.9820. Epub 2012 Oct 8.

PMID:
23045594
[PubMed - indexed for MEDLINE]
Free Article
7.

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas.

Petty WJ, Aklilu M, Varela VA, Lovato J, Savage PD, Miller AA.

BMC Cancer. 2012 Sep 11;12:404. doi: 10.1186/1471-2407-12-404.

PMID:
22963500
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer.

Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KH.

Lung Cancer. 2011 Dec;74(3):384-91. doi: 10.1016/j.lungcan.2011.04.004. Epub 2011 May 8.

PMID:
21555162
[PubMed - indexed for MEDLINE]
9.

Effects of continued tobacco use during treatment of lung cancer.

Waller LL, Weaver KE, Petty WJ, Miller AA.

Expert Rev Anticancer Ther. 2010 Oct;10(10):1569-75. doi: 10.1586/era.10.140. Review.

PMID:
20942628
[PubMed - indexed for MEDLINE]
10.

A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer.

Center B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J, Oaks T, Miller AA, Blackstock AW.

J Thorac Oncol. 2010 Jan;5(1):69-74. doi: 10.1097/JTO.0b013e3181c59a0e.

PMID:
20035186
[PubMed - indexed for MEDLINE]
11.

Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.

Petty WJ, Miller AA, McCoy TP, Gallagher PE, Tallant EA, Torti FM.

Clin Cancer Res. 2009 Dec 1;15(23):7398-404. doi: 10.1158/1078-0432.CCR-09-1957. Epub 2009 Nov 17.

PMID:
19920106
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke.

Waller LL, Miller AA, Petty WJ.

Lung Cancer. 2010 Jan;67(1):12-6. doi: 10.1016/j.lungcan.2009.08.014. Epub . Review.

PMID:
19762110
[PubMed - indexed for MEDLINE]
13.

Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers.

Hughes AN, O'Brien ME, Petty WJ, Chick JB, Rankin E, Woll PJ, Dunlop D, Nicolson M, Boinpally R, Wolf J, Price A.

J Clin Oncol. 2009 Mar 10;27(8):1220-6. doi: 10.1200/JCO.2008.19.3995. Epub 2009 Jan 21.

PMID:
19164205
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Distinct functions of retinoic acid receptor beta isoforms: implications for targeted therapy.

Swift CB, Hays JL, Petty WJ.

Endocr Metab Immune Disord Drug Targets. 2008 Mar;8(1):47-50. Review.

PMID:
18393922
[PubMed - indexed for MEDLINE]
15.

Targeting the epidermal growth factor receptor in high-grade astrocytomas.

Voelzke WR, Petty WJ, Lesser GJ.

Curr Treat Options Oncol. 2008 Feb;9(1):23-31. doi: 10.1007/s11864-008-0053-5. Epub 2008 Feb 5. Review.

PMID:
18247132
[PubMed - indexed for MEDLINE]
16.

The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database.

Lally BE, Detterbeck FC, Geiger AM, Thomas CR Jr, Machtay M, Miller AA, Wilson LD, Oaks TE, Petty WJ, Robbins ME, Blackstock AW.

Cancer. 2007 Aug 15;110(4):911-7.

PMID:
17620279
[PubMed - indexed for MEDLINE]
Free Article
17.

A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer.

Petty WJ, Knight SN, Mosley L, Lovato J, Capellari J, Tucker R, Blackstock AW, Miller MS, Miller AA.

J Thorac Oncol. 2007 Mar;2(3):197-202.

PMID:
17410042
[PubMed - indexed for MEDLINE]
18.

A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer.

Dragnev KH, Petty WJ, Shah SJ, Lewis LD, Black CC, Memoli V, Nugent WC, Hermann T, Negro-Vilar A, Rigas JR, Dmitrovsky E.

Clin Cancer Res. 2007 Mar 15;13(6):1794-800.

PMID:
17363535
[PubMed - indexed for MEDLINE]
Free Article
19.

Frequent requirement of hedgehog signaling in non-small cell lung carcinoma.

Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, Memoli VA, Dmitrovsky E, Robbins DJ.

Oncogene. 2007 Feb 15;26(7):1046-55. Epub 2006 Aug 14.

PMID:
16909105
[PubMed - indexed for MEDLINE]
20.

Bexarotene and erlotinib for aerodigestive tract cancer.

Dragnev KH, Petty WJ, Shah S, Biddle A, Desai NB, Memoli V, Rigas JR, Dmitrovsky E.

J Clin Oncol. 2005 Dec 1;23(34):8757-64.

PMID:
16314636
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk